Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis

Journal of Infection

Volumn 81, Issue 2, 2020, Pages e16-e25

  Zheng, Zhaohai ^a,b   Peng, Fang ^a   Xu, Buyun ^a   Zhao, Jingjing ^a,b   Liu, Huahua ^c   Peng, Jiahao ^d   Li, Qingsong ^e   Jiang, Chongfu ^e   Zhou, Yan ^a   Liu, Shuqing ^a,f   Ye, Chunji ^a   Zhang, Peng ^a   Xing, Yangbo ^a   Guo, Hangyuan ^a   Tang, Weiliang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^d LOMA LINDA UNIVERSITY   (United States)

^e Awati County People's Hospital   (China)

^f SHAOXING UNIVERSITY   (China)

Author keywords

Clinical manifestation; Comorbidity; COVID 19; Laboratory examination; Risk factor

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATININE; D DIMER; PROCALCITONIN; TROPONIN I;

AGE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CORONAVIRUS DISEASE 2019; DIABETES MELLITUS; DISEASE EXACERBATION; DYSPNEA; FEVER; GENDER; HEALTH STATUS; HUMAN; HYPERTENSION; LEUKOCYTE COUNT; RESPIRATORY TRACT DISEASE; REVIEW; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW; ACUTE DISEASE; ADULT; AGED; CORONAVIRUS INFECTION; FEMALE; MALE; META ANALYSIS; MIDDLE AGED; MORTALITY; PANDEMIC; PATHOLOGY; SEVERITY OF ILLNESS INDEX; SEX FACTOR; VIRUS PNEUMONIA;

ACUTE DISEASE; ADULT; AGE FACTORS; AGED; CORONAVIRUS INFECTIONS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS;

EID: 85083878865     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2020.04.021     Document Type: Review

References (28)

1. Chan J, F, Yuan, S, Kok K, H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.[J]. Lancet 395:10223 (2020), 514–523, 10.1016/s0140-6736(20)30154-9.
2. Zhou, P, Yang X, L, Wang X, G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin.[J]. Nature 579:7798 (2020), 270–273, 10.1038/s41586-020-2012-7.
3. Lai C, C, Wang C, Y, Wang Y, H, et al. Global epidemiology of coronavirus disease 2019: disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status.[J]. Int J Antimicrob Agents, 2020, 105946, 10.1016/j.ijantimicag.2020.105946.
4. Slim, K, Nini, E, Forestier, D, et al. Methodological index for non-randomized studies (minors): development and validation of a new instrument.[J]. ANZ J Surg 73:9 (2003), 712–716, 10.1046/j.1445-2197.2003.02748.x.
5. Guan W, J, Ni Z, Y, Hu, Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China.[J]. N Engl J Med, 2020, 10.1056/NEJMoa2002032.
6. Huang, C, Wang, Y, Li, X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.[J]. Lancet 395:10223 (2020), 497–506, 10.1016/s0140-6736(20)30183-5.
7. Mo, P, Xing, Y, Xiao, Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China.[J]. Clin Infect Dis, 2020, 10.1093/cid/ciaa270.
8. Peng Y, D, Meng, K, Guan H, Q, et al. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV].[J]. Zhonghua Xin Xue Guan Bing Za Zhi, 48(0), 2020, E004, 10.3760/cma.j.cn112148-20200220-00105.
9. Shi, Y, Yu, X, Zhao, H, et al. Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan.[J]. Crit Care, 24(1), 2020, 108, 10.1186/s13054-020-2833-7.
10. Tang, N, Li, D, Wang, X, et al. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia.[J]. J Thromb Haemost, 2020, 10.1111/jth.14768.
11. Tian, S, Hu, N, Lou, J, et al. Characteristics of COVID-19 infection in Beijing.[J]. J Infect 80:4 (2020), 401–406, 10.1016/j.jinf.2020.02.018.
12. Wang, D, Hu, B, Hu, C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.[J]. Jama, 2020, 10.1001/jama.2020.1585.
13. Wang, Z, Yang, B, Li, Q, et al. Clinical Features of 69 Cases with Coronavirus Disease 2019 in Wuhan, China.[J]. Clin Infect Dis, 2020, 10.1093/cid/ciaa272.
14. Wu, C, Chen, X, Cai, Y, et al. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.[J]. JAMA Intern Med, 2020, 10.1001/jamainternmed.2020.0994.
15. Yang, X, Yu, Y, Xu, J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.[J]. Lancet Respir Med, 2020, 10.1016/s2213-2600(20)30079-5.
16. Yuan, M, Yin, W, Tao, Z, et al. Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China.[J]. PLoS One, 15(3), 2020, e0230548, 10.1371/journal.pone.0230548.
17. Zhou, F, Yu, T, Du, R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.[J]. Lancet, 2020 doi: 10.1016/s0140-6736(20)30566-3.
18. Fehr A, R, Perlman, S, Coronaviruses: an overview of their replication and pathogenesis.[J]. Methods Mol Biol 1282 (2015), 1–23, 10.1007/978-1-4939-2438-7_1.
19. Ding, Q, Lu, P, Fan, Y, et al. The clinical characteristics of pneumonia patients coinfected with 2019 novel coronavirus and influenza virus in Wuhan, China.[J]. J Med Virol, 2020, 10 doi: 10.1002/jmv.25781.
20. Tipnis S, R, Hooper N, M, Hyde, R, et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase.[J]. J Biol Chem 275:43 (2000), 33238–33243, 10.1074/jbc.M002615200.
21. Griendling K, K, Sorescu, D, Lassegue, B, et al. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology.[J]. Arterioscler Thromb Vasc Biol 20:10 (2000), 2175–2183, 10.1161/01.atv.20.10.2175.
22. Vickers, C, Hales, P, Kaushik, V, et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase.[J]. J Biol Chem 277:17 (2002), 14838–14843, 10.1074/jbc.M200581200.
23. Santos R, A, Simoes e Silva, A.C, Maric, C, et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas.[J]. Proc Natl Acad Sci U S A 100:14 (2003), 8258–8263, 10.1073/pnas.1432869100.
24. Glowacka, I, Bertram, S, Herzog, P, et al. Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63.[J]. J Virol 84:2 (2010), 1198–1205, 10.1128/jvi.01248-09.
25. Xu, Z, Shi, L, Wang, Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome.[J]. Lancet Respir Med 8:4 (2020), 420–422, 10.1016/s2213-2600(20)30076-x.
26. Chen, N, Zhou, M, Dong, X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.[J]. Lancet 395:10223 (2020), 507–513, 10.1016/s0140-6736(20)30211-716/s2213-2600(20)30076-x.
27. Castrucci M, R., Factors affecting immune responses to the influenza vaccine.[J]. Hum Vaccin Immunother 14:3 (2018), 637–646, 10.1080/21645515.2017.1338547.
28. Gal-Oz S, T, Maier, B, Yoshida, H, et al. ImmGen report: sexual dimorphism in the immune system transcriptome.[J]. Nat Commun, 10(1), 2019, 4295, 10.1038/s41467-019-12348-6.